Intraperitoneal administration of activin A promotes development of endometriotic lesions in a mouse model of endometriosis

Kana Kasai, Kasai K, Kato T, Takeshi Kato, Kadota Y, Yuri Kadota, Otgontsetseg Erdenebayar, Keyama K, Kaoru Keyama, Kawakita T, Takako Kawakita, Yoshida K, Kanako Yoshida, Akira Kuwahara, Kuwahara A, Toshiya Matsuzaki, Matsuzaki T, Minoru Irahara, Irahara M
The journal of medical investigation : JMI · 2019 · vol. 66(1.2) , pp. 123–127 · doi:10.2152/jmi.66.123 · PMID:31064924 · W2941439294
Lab / animal OA: diamond CC0 ⤵ 6 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-14 ⓘ

Intraperitoneal administration of activin A in a mouse model significantly increased endometriotic lesion size and inflammatory cytokine levels compared to controls.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-14 · read from full text ⓘ

The paper studied whether intraperitoneal administration of activin A affects the development of endometriotic lesions in a mouse model. C57BL/6J 7–8-week-old recipient mice received intraperitoneal inoculation with donor mouse endometrial tissue and blood to induce endometriosis, and activin A (400 μg intraperitoneally for 5 days) was compared with a control condition. Activin A–treated mice had significantly larger maximum lesion diameters and greater total lesion area, and their washed ascites showed higher IL-6 and TNF-α levels. This study supports a role for activin in promoting lesion development and inflammation, and this paper is centrally about endometriosis—intraperitoneal activin A administration to promote endometriotic lesion development in mice.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: This study aimed to investigate the effect of intraperitoneal administration of activin on the occurrence of endometriosis using a mouse model of endometriosis. METHODS: A mouse model of endometriosis was prepared by intraperitoneally administering endometrial tissue and blood collected from donor mice to C57BL/6J 7-8- week-old recipient mice. A total of 400 μg of activin A was intraperitoneally administered to model mice in the activin group for 5 days. Intraperitoneal endometriotic lesions were confirmed macroscopically and IL-6 and TNF-α levels in washed ascites were measured by ELISA. RESULTS: Endometriotic lesions were observed in all mice. In the activin group, the maximum diameter of endometriotic lesions was significantly larger than that in control group (4.7?1.3 vs 2.9?0.9 mm, p?0.01). The total area of the lesion was also significantly higher in the activin group than in the control group (21.1?9.9 vs 8.8?5.4 mm2,p?0.01). Furthermore, IL-6 and TNF-α levels in ascites were significantly higher in the activin group than in the control group (IL-6 : 85.8?15.3 vs 75.1?19.3 pg/ml, p?0.05 ; TNF-α : 629.8?15.4 vs 605.9?11.4 pg/ml, p?0.05). CONCLUSION: Activin promotes occurrence of endometriosis. Inflammatory cytokines are also elevated by activin administration,suggesting that they may contribute to progression of endometriosis J. Med. Invest. 66 : 123-127, February, 2019.
Full text 1,694 characters · extracted from oa-doi-fallback · click to expand
Intraperitoneal administration of activin A promotes development of endometriotic lesions in a mouse model of endometriosis 2019 Volume 66 Issue 1.2 Pages 123-127 Details Abstract PURPOSE : This study aimed to investigate the effect of intraperitoneal administration of activin on the occurrence of endometriosis using a mouse model of endometriosis. METHODS : A mouse model of endometriosis was prepared by intraperitoneally administering endometrial tissue and blood collected from donor mice to C57BL/6J 7-8- week-old recipient mice. A total of 400 μg of activin A was intraperitoneally administered to model mice in the activin group for 5 days. Intraperitoneal endometriotic lesions were confirmed macroscopically and IL-6 and TNF-α levels in washed ascites were measured by ELISA. RESULTS : Endometriotic lesions were observed in all mice. In the activin group, the maximum diameter of endometriotic lesions was significantly larger than that in control group (4.7?1.3 vs 2.9?0.9 mm, p?0.01). The total area of the lesion was also significantly higher in the activin group than in the control group (21.1?9.9 vs 8.8?5.4 mm2,p?0.01). Furthermore, IL-6 and TNF-α levels in ascites were significantly higher in the activin group than in the control group (IL-6 : 85.8?15.3 vs 75.1?19.3 pg/ml, p?0.05 ; TNF-α : 629.8?15.4 vs 605.9?11.4 pg/ml, p?0.05). CONCLUSION : Activin promotes occurrence of endometriosis. Inflammatory cytokines are also elevated by activin administration,suggesting that they may contribute to progression of endometriosis J. Med. Invest. 66 : 123-127, February, 2019 © 2019 by The University of Tokushima Faculty of Medicine Favorites & Alerts Recently viewed articles

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Activins Disease Models, Animal Disease Models, Animal Endometriosis Activins Activins Activins Animals Animals Endometriosis Endometriosis Endometriosis Female Female Injections, Intraperitoneal Injections, Intraperitoneal Interleukin-6 Interleukin-6 Interleukin-6 Mice

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (30)

Cited by (6)

Source provenance

europepmc
last seen: 2026-10-19T06:17:24.038039+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:24:31.663940+00:00
License: CC0 · commercial use OK